Galaxy Digital Inc. (GLXY)
NASDAQ: GLXY · Real-Time Price · USD
28.09
+0.75 (2.74%)
At close: Aug 7, 2025, 4:00 PM
28.58
+0.49 (1.74%)
Pre-market: Aug 8, 2025, 5:18 AM EDT
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts that cover Longboard Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $36.67, which forecasts a 30.54% increase in the stock price over the next year. The lowest target is $34 and the highest is $40.
Price Target: $36.67 (+30.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Longboard Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 |
|---|---|---|
| Strong Buy | 4 | 5 |
| Buy | 1 | 1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $33 → $34 | Strong Buy | Maintains | $33 → $34 | +21.04% | Aug 7, 2025 |
| Rosenblatt | Rosenblatt | Strong Buy Maintains $36 → $35 | Strong Buy | Maintains | $36 → $35 | +24.60% | Aug 6, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $38 → $40 | Strong Buy | Maintains | $38 → $40 | +42.40% | Aug 6, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +42.40% | Jul 31, 2025 |
| Rosenblatt | Rosenblatt | Strong Buy Maintains $25 → $36 | Strong Buy | Maintains | $25 → $36 | +28.16% | Jul 25, 2025 |
Financial Forecast
Revenue This Year
9.26B
Revenue Next Year
17.27B
from 9.26B
Increased by 86.39%
EPS This Year
0.58
from 0.55
Increased by 5.71%
EPS Next Year
0.43
from 0.58
Decreased by -25.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 53.2B | 68.3B | 90.8B |
| Avg | 9.3B | 17.3B | 30.2B |
| Low | 411.6M | 411.6M | 287.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 637.4% | 426.1% |
| Avg | - | 86.4% | 74.8% |
| Low | - | -95.6% | -98.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.84 | 1.64 | 1.46 |
| Avg | 0.58 | 0.43 | 1.42 |
| Low | -1.04 | -1.02 | 1.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 234.1% | 181.7% | 238.0% |
| Avg | 5.7% | -25.7% | 228.3% |
| Low | - | - | 215.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.